https://www.indianpharmapost.com/zydus-receives-final-approval-from-usfda-for-two-tablets-129422022-09-01T00:00:00+05:30always0.9https://www.indianpharmapost.com/merck-india-inaugurates-rd-excellence-centre-in-bangalore-129512022-09-01T00:00:00+05:30always0.9https://www.indianpharmapost.com/biological-e-announces-cdsco-recommendation-of-its-infants-vaccine-129502022-09-01T00:00:00+05:30always0.9https://www.indianpharmapost.com/medix-biochemica-appoints-former-roche-executive-to-its-board-of-directors-129492022-09-01T00:00:00+05:30always0.9https://www.indianpharmapost.com/hydration-of-proteins-could-act-as-a-potential-marker-for-an-early-detection-of-neuro-degenerative-diseases-129482022-09-01T00:00:00+05:30always0.9https://www.indianpharmapost.com/bayer-initiates-phase-iii-study-program-to-investigate-oral-fxia-inhibitor-asundexian-129472022-09-01T00:00:00+05:30always0.9https://www.indianpharmapost.com/a-10-year-commission-with-dedicated-mission-is-required-to-tackle-the-upsurge-of-diabetes-in-india-says-expert-129462022-09-01T00:00:00+05:30always0.9https://www.indianpharmapost.com/bayer-showcases-cancer-study-data-at-esmo-congress-2022-129452022-09-01T00:00:00+05:30always0.9https://www.indianpharmapost.com/stelis-biopharmas-flagship-facility-receives-eir-from-usfda-129442022-09-01T00:00:00+05:30always0.9https://www.indianpharmapost.com/us-fda-issues-17-observations-for-biocon-biologics-sites-129432022-09-01T00:00:00+05:30always0.9https://www.indianpharmapost.com/daiichi-sankyo-announces-initiation-of-phase-3-trial-of-mrna-129522022-09-01T00:00:00+05:30always0.9